Briefing Information for the July 25, 2018 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
FDA
- FDA Briefing Information for the July 25, 2018 Meeting of the Pulmonary-Allergy Drugs Advisory Committee
- Errata to the FDA Briefing Information for the July 25, 2018 Meeting of the Pulmonary-Allergy Drugs Advisory Committee
GlaxoSmithKline
Contact Information
- FDA Advisory Committee Information Line
- 1-800-741-8138
- (301-443-0572 in the Washington DC area)
Please call the Information Line for up-to-date information on this meeting.